Patent · US Active

Anti-LAG-3 antibodies and uses thereof

US10577421B2 · kind B2 · utility

2Cited by

0References

11Claims

0Family size

Assignee

I-MAB · KY

Inventors

Lei Fang · Katy, US
Zhengyi Wang · Shanghai, CN
Bingshi Guo · Shanghai, CN
Jingwu Zang · Shanghai, CN
Wenqing Jiang · Shanghai, CN
Yongqiang Wang · Shanghai, CN

Key dates

Filing date	Feb 22, 2018
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Feb 22, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.